Evolutionary Genomics Inc. Stock Analysis FNAM
Evolutionary Genomics, Inc. is a genomics research and development company, which engages in the identification and validation of genes. The company is headquartered in Castle Rock, Colorado and currently employs 2 full-time employees. The company went IPO on 2011-03-03. The firm is focused on the identification and validation of genes that impact commercially valuable traits in crops for the agriculture industry. The company has performed research on crops including rice, corn, soybeans, wheat, cotton, cowpeas, beans, tomatoes, and cassava. Its core technology is its patented Adapted Traits Platform (ATP), which is used to perform molecular evolution analysis to identify positively selected genes that may have an impact on traits of interest. Positively selected candidate genes must be further tested to validate their impact on the desired traits. The firm has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes and cotton.
Read More Evolutionary Genomics Inc (FNAM) Chart
Key Statistics of Evolutionary Genomics Inc (FNAM)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
-P/E Ratio (TTM)
-52 Week Range
Market Cap
1331.00Avg. Volume
-Dividend Yield
-Financial Metrics & Statements of Evolutionary Genomics Inc (FNAM)
FAQ's for Evolutionary Genomics Inc (FNAM)
- According to Musaffa’s Shariah screening methodology, Evolutionary Genomics Inc (FNAM) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.